Insulet (PODD) Asset Writedowns and Impairment (2016 - 2025)
Insulet's Asset Writedowns and Impairment history spans 16 years, with the latest figure at $100000.0 for Q3 2025.
- For Q3 2025, Asset Writedowns and Impairment changed N/A year-over-year to $100000.0; the TTM value through Sep 2025 reached $4.3 million, up 437.5%, while the annual FY2024 figure was -$200000.0, 108.7% down from the prior year.
- Asset Writedowns and Impairment reached $100000.0 in Q3 2025 per PODD's latest filing, down from $300000.0 in the prior quarter.
- In the past five years, Asset Writedowns and Impairment ranged from a high of $4.8 million in Q1 2025 to a low of -$900000.0 in Q4 2024.
- Average Asset Writedowns and Impairment over 5 years is $805555.6, with a median of $750000.0 recorded in 2021.
- Peak YoY movement for Asset Writedowns and Impairment: skyrocketed 450.0% in 2022, then tumbled 550.0% in 2024.
- A 5-year view of Asset Writedowns and Impairment shows it stood at $300000.0 in 2021, then skyrocketed by 266.67% to $1.1 million in 2022, then plummeted by 81.82% to $200000.0 in 2023, then crashed by 550.0% to -$900000.0 in 2024, then soared by 111.11% to $100000.0 in 2025.
- Per Business Quant, the three most recent readings for PODD's Asset Writedowns and Impairment are $100000.0 (Q3 2025), $300000.0 (Q2 2025), and $4.8 million (Q1 2025).